Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
US Army
Fuji
McKesson
Argus Health
Moodys
Julphar
Federal Trade Commission
Express Scripts

Generated: February 24, 2018

DrugPatentWatch Database Preview

TIAMATE Drug Profile

« Back to Dashboard

When do Tiamate patents expire, and when can generic versions of Tiamate launch?

Tiamate is a drug marketed by Merck and is included in one NDA.

The generic ingredient in TIAMATE is diltiazem malate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate profile page.

US Patents and Regulatory Information for TIAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TIAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-003 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-001 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Merck TIAMATE diltiazem malate TABLET, EXTENDED RELEASE;ORAL 020506-002 Oct 4, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Farmers Insurance
Express Scripts
Fuji
Chinese Patent Office
Cerilliant
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot